Morgan Stanley’s Enviva Inc. EVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-41,750
| Closed | -$16.9K | – | 8229 |
|
|
2024
Q3 | $16.9K | Sell |
41,750
-9,341
| -18% | -$4.07K | ﹤0.01% | 6551 |
|
|
2024
Q2 | $22K | Sell |
51,091
-6,123
| -11% | -$3.08K | ﹤0.01% | 6425 |
|
|
2024
Q1 | $25.2K | Sell |
57,214
-1,511,724
| -96% | -$793K | ﹤0.01% | 6424 |
|
|
2023
Q4 | $1.56M | Buy |
1,568,938
+851,229
| +119% | +$2.36M | ﹤0.01% | 5076 |
|
|
2023
Q3 | $5.36M | Sell |
717,709
-1,695,074
| -70% | -$17.6M | ﹤0.01% | 3681 |
|
|
2023
Q2 | $26.2M | Buy |
2,412,783
+1,378,787
| +133% | +$20.1M | ﹤0.01% | 2192 |
|
|
2023
Q1 | $29.9M | Buy |
1,033,996
+802,019
| +346% | +$32.7M | ﹤0.01% | 2014 |
|
|
2022
Q4 | $12.3M | Buy |
231,977
+73,935
| +47% | +$4.23M | ﹤0.01% | 2876 |
|
|
2022
Q3 | $9.49M | Sell |
158,042
-164,181
| -51% | -$11M | ﹤0.01% | 3034 |
|
|
2022
Q2 | $18.4M | Buy |
322,223
+63,351
| +24% | +$4.77M | ﹤0.01% | 2383 |
|
|
2022
Q1 | $20.5M | Sell |
258,872
-10,905
| -4% | -$796K | ﹤0.01% | 2086 |
|
|
2021
Q4 | $19M | Sell |
269,777
-10,579
| -4% | -$708K | ﹤0.01% | 2213 |
|
|
2021
Q3 | $15.2M | Sell |
280,356
-53,594
| -16% | -$2.88M | ﹤0.01% | 2396 |
|
|
2021
Q2 | $17.5M | Buy |
333,950
+107,015
| +47% | +$5.28M | ﹤0.01% | 2305 |
|
|
2021
Q1 | $11M | Sell |
226,935
-143,441
| -39% | -$7.09M | ﹤0.01% | 2552 |
|
|
2020
Q4 | $16.8M | Sell |
370,376
-273,047
| -42% | -$11.9M | ﹤0.01% | 1970 |
|
|
2020
Q3 | $25.9M | Buy |
643,423
+289,688
| +82% | +$11.4M | 0.01% | 1295 |
|
|
2020
Q2 | $12.7M | Buy |
353,735
+22,677
| +7% | +$753K | ﹤0.01% | 1762 |
|
|
2020
Q1 | $8.85M | Buy |
331,058
+24,193
| +8% | +$841K | ﹤0.01% | 1898 |
|
|
2019
Q4 | $11.4M | Buy |
306,865
+26,809
| +10% | +$911K | ﹤0.01% | 2274 |
|
|
2019
Q3 | $8.95M | Sell |
280,056
-105,960
| -27% | -$3.26M | ﹤0.01% | 2244 |
|
|
2019
Q2 | $12.1M | Buy |
386,016
+122,651
| +47% | +$3.89M | ﹤0.01% | 1952 |
|
|
2019
Q1 | $8.49M | Buy |
263,365
+58,247
| +28% | +$1.74M | ﹤0.01% | 2191 |
|
|
2018
Q4 | $5.69M | Buy |
205,118
+155,566
| +314% | +$4.6M | ﹤0.01% | 2741 |
|
|
2018
Q3 | $1.57M | Buy |
49,552
+4,663
| +10% | +$143K | ﹤0.01% | 4188 |
|
|
2018
Q2 | $1.31M | Sell |
44,889
-38,671
| -46% | -$1.12M | ﹤0.01% | 4435 |
|
|
2018
Q1 | $2.29M | Buy |
83,560
+51,734
| +163% | +$1.42M | ﹤0.01% | 3876 |
|
|
2017
Q4 | $880K | Buy |
31,826
+5,764
| +22% | +$166K | ﹤0.01% | 4627 |
|
|
2017
Q3 | $770K | Sell |
26,062
-28,016
| -52% | -$808K | ﹤0.01% | 4602 |
|
|
2017
Q2 | $1.49M | Sell |
54,078
-18,128
| -25% | -$509K | ﹤0.01% | 4055 |
|
|
2017
Q1 | $2.03M | Sell |
72,206
-1,008
| -1% | -$27.9K | ﹤0.01% | 3796 |
|
|
2016
Q4 | $1.96M | Sell |
73,214
-155,717
| -68% | -$4.23M | ﹤0.01% | 3947 |
|
|
2016
Q3 | $6.18M | Sell |
228,931
-348,370
| -60% | -$8.43M | ﹤0.01% | 2467 |
|
|
2016
Q2 | $13.1M | Sell |
577,301
-562,694
| -49% | -$12.5M | ﹤0.01% | 1755 |
|
|
2016
Q1 | $24.8M | Sell |
1,139,995
-335,118
| -23% | -$6.31M | 0.01% | 1190 |
|
|
2015
Q4 | $26.8M | Sell |
1,475,113
-387,726
| -21% | -$5.9M | 0.01% | 1196 |
|
|
2015
Q3 | $23.3M | Sell |
1,862,839
-125,657
| -6% | -$1.83M | 0.01% | 1259 |
|
|
2015
Q2 | $36M | Buy |
+1,988,496
| New | +$40M | 0.01% | 1061 |
|
Other funds holding EVA
Morgan Stanley's EVA Position: Q4 2024 in Review
Morgan Stanley sold out of Enviva Inc. (EVA) in Q4 2024, closing a stake of 41,750 shares — an estimated $16.9K sold.
Morgan Stanley first reported a position in EVA in Q2 2015 and held it in 38 quarters. The position peaked at $36M in Q2 2015. 1 fund tracked by Wall St. Rank holds EVA as of Q4 2024.
- Morgan Stanley reported no remaining Enviva Inc. position as of Q4 2024 after selling out during the quarter.
- Morgan Stanley sold 41,750 Enviva Inc. shares in Q4 2024, an estimated $16.9K.
- Morgan Stanley first reported a position in Enviva Inc. in Q2 2015 and held it in 38 quarters.
- Morgan Stanley's Enviva Inc. position peaked at $36M in Q2 2015.
- 1 fund tracked by Wall St. Rank held Enviva Inc. as of Q4 2024.
Based on Morgan Stanley's 13F filing for Q4 2024, filed 14 Feb 2025.